Subject Category Author Posted Rep. last R. [asc] Views
Regulatives / Guidelines patel_prakash79 2006-05-19 07:56 1 2006-05-19 11:25 15,531
Design Issues chandramohan 2006-05-26 19:51 1 2006-05-29 12:28 10,005
Regulatives / Guidelines Helmut 2006-05-31 12:01 0   5,392
Software valen 2006-06-15 12:19 1 2006-06-15 11:08 9,487
Design Issues nguyenvo 2006-06-13 21:11 3 2006-06-15 12:26 11,380
Design Issues Essar 2006-01-12 04:47 12 2006-06-24 10:45 30,943
Design Issues joyjac 2006-06-28 06:56 1 2006-07-05 12:54 8,562
Outliers joyjac 2006-01-27 01:39 3 2006-07-10 10:41 18,566
Design Issues chandramohan 2006-05-04 05:39 4 2006-07-11 05:38 10,487
Regulatives / Guidelines devender_naik 2006-04-27 10:12 2 2006-07-11 05:43 8,304
Design Issues atul 2006-01-18 12:04 2 2006-07-11 05:50 9,746
Study Per­for­mance SIVAPRASAD 2006-02-06 05:05 3 2006-07-11 05:59 9,511
Design Issues roody 2005-08-06 14:01 5 2006-07-11 06:09 23,647
Regulatives / Guidelines chintan98 2006-07-12 09:18 1 2006-07-12 10:32 7,738
Outliers velupharm 2006-07-13 08:39 3 2006-07-16 10:52 11,311
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
122 visitors (0 registered, 122 guests [including 6 identified bots]).
Forum time: 00:30 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5